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Abstract Synthetic elastin peptides, VPGVG or its polymer 
(VPGVG),, enhanced the proliferation of smooth muscle cells 
1.5-fold during 48 h treatment at the concetrations over 10 -6 M 
or 1.0 pg/ml, respectively. Monomeric and polymeric VPGVG 
sequences reduced elastin synthesis and its mRNA level to one- 
third and one-half of control respectively under the conditions in 
which the proliferation of cells were enhanced, but did not change 
collagen synthesis as measured by bacterial collagenase digestion. 
The elastin-specific autoregulation by elastin fragments may re- 
flect the feedback regulation of elastin expression which may play 
an essential role in elastin metabolism under the normal and 
diseased conditions. 
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1. Introduction 
Elastin is a major connective tissue component in aortic wall 
and confers elasticity to the tissues [1]. Overproduction of 
elastin is thought to be responsible for the development of 
atherosclerosis [2]. The synthesis of elastin has been demon- 
strated to be regulated by many growth factors or cytokines [3]. 
However, understanding of overall regulation of elastin synthe- 
sis is not sufficient. 
Elastin has unique repeating sequence in the hydrophobic 
region; tetrapeptide VPGX (X = G or A), pentapeptide 
VPGVG, hexapeptide XPGVGV (X = A or V), and nonapep- 
tide VPGXGVGAG (X = L or F). Pentapeptide VPGVG is the 
only repeating sequence present in the elastin molecules of all 
animal species analyzed including human, bovine, porcine and 
chicken [4~9]. VGVAPG is a hexapeptide repeated multiple 
times in the human, bovine and porcine elastin molecules but 
not present in chicken elastin molecule [4,10]. This sequence is 
active as a chemoattractant for monocytes, elastin-producing 
fibroblasts [11] and tumor cells [12], and modulates protein 
kinase C activity in lung carcinoma cells [13]. However, it is not 
known whether or not the elastin fragments act on the biosyn- 
thetic properties of elastin of the cells. 
*Corresponding author. Fax: (81) (3) 3351-6880. 
Abbreviations: BAPN, fl-aminopropionitril; EDTA, ethylenediamine- 
tetraacetic a id; NEM, N-ethylmaleimide; NMR, nuclear magnetic res- 
onance; PMSF, phenylmethylsulfonyl fluoride; SDS-PAGE, sodium 
dodecylsulfate-polyacrylamide gel el ctrophoresis; SSC, 0.15 M sodium 
chloride and 0.015 M sodium citrate; TCA, trichloroacetic a id; TPA, 
12-O-tetradecanoylphorbol-I 3-acetate. 
In this studies, we synthesized a pentapeptide VPGVG which 
is present in chicken elastin molecule and repeats multiple 
times, and found that the elastin fragment could modulate the 
biosynthetic phenotype of elastin at a pretranslational level and 
stimulate cell motility in the monolayered chick vascular SMCs. 
This is the first report concerning the autoregulation of elastin 
expression by an elastin fragment. 
2. Materials and methods 
2.1. Cell culture and treatment with the peptidcs 
SMCs were isolated from aortas of 20-day-old chick embryos by a 
serial enzyme digestion (0.05% bacterial collagenase and 0.025% pan- 
creatic elastase) [14]. The cells were plated at a density of 2.2 × 105 
cell/cm 2 in 35- or 100-mm diameter dish (Falcon) and grown to pre- 
confluent density in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) in a humidified at- 
mosphere of 5% CO2 in air at 37°C. The cells at a primary culture were 
used in this experiments, unless indicated otherwise. To bring the cells 
to quiescent state, cultures of confluent cells were placed in 0.5% FBS 
for 48 h, then treated with various concentrations of elastin-derived 
peptides or TPA for indicated periods. 
2.2. Effects of elastin peptides on cell prol![eration 
Cells were treated with trypsin (0.25%) and the cell number was 
determined with a Coulter counter. 
2.3. Synthesis of elastin peptides 
The peptides, (GVP)2 , VPGVG, and VGVAPG were synthesized by 
a solid-phase method. (VPGVG), and (VGVAPG), were synthesized as 
previously described [15,16]. The average value of n in both polymers 
was determined to be greater than 40 by NMR analysis. 
2.4. Synthesis of elastin 
The cultures treated with various peptides were labeled with [3,4- 
3H]valine (20/ICi/ml) (2.1 TBq/mmol; Amersham) for the last 6 h of 
the treatment in valine-free DMEM (Gibco). 
The proteins in the medium and cell extracts with 0.5 M acetic acid 
were separately precipitated with 30% ammonium sulfate in the pres- 
ence of protease inhibitor cocktails (1 mM EDTA, NEM and PMSF), 
and resolved on 4-15% gradient SDS-PAGE followed by fluorography. 
Elastin synthesis relative to total protein synthesis was determined by 
scanning the fluorograms with a densitometer (Cliniscan, Helena Lab.) 
[17]. The cell number was determined after trypsin treatment with a 
Coulter counter. The amount of sample applied to SDS-PAGE was 
normalized to the cell number. 
2.5. Synthesis of collagen 
Cells were labeled with [2,3-3H]proline (50/ICi/ml) (4.0 TBq/mmol; 
Amersham) for the last 6 h of the treatment in the presence of ascorbic 
acid (50/lg/ml). The proteins from medium and cell layer were com- 
bined and stored -20°C until ready for analysis. The amount of radio- 
activity incorporated into collagen was determined using purified bacte- 
rial collagenase [18] as previously described [19]. 
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2.6. Northern blot analysis 
Total RNA was extracted from cultured cells as described previously 
[20] and stored at the concentration of 1/.tg//ll at -80°C. RNA was 
denatured in 1 M glyoxal at 50°C for 1 h and resolved by electropho- 
resis on 1% agarose gel (10pg RNA/lane), then blotted to nylon mem- 
brane filters (Pall Biosupport). The filters were hybridized in the solu- 
tion (50% deionized formamide, 5× Denhardt's olution, 0.1% SDS, 
5 x SSC and 100 ,ug/ml tRNA) at 42°C for 24 h with appropriate 
32P-labeled cDNA probes. The cDNAs for chicken elastin [21], glycer- 
aldehyde-3-phosphate dehydrogenase (GAPDH) [22] were labeled with 
[32p]dCTP to a specific activity of ~ 108 cpm/ctg DNA using multiprime 
DNA labeling system (Amersham). Filters were washed with two 
changes of 2 x SSC/0.1% SDS at room temperature for 30 min, then 
with two changes of 0.1 x SSC/0.1% for 30 min. Filters were air-dried 
and autoradiographed. The autoradiograms were scanned with a den- 
sitometer. 
3. Results 
The elastin peptides, VPGVG monomer and polymer (Fig. 
lc and e) enhanced SMC proliferation (1.5-fold) to the same 
extent as TPA (1.6-fold) (Fig. la). The peptides, monomer and 
polymer of VGVAPG, showed no significant effect on cell 
proliferation (Fig. ld and f). Treatment of the cells with (VGV)2 
resulted in a slight increase in cell proliferation but to lesser 
extent han VPGVG monomer or polymer (Fig. l b). Based on 
these results, further experiments on elastin expression were 
performed with monomer and polymer of VPGVG, using 
VGVAPG as a negative control. 
Elastin level in the culture medium was inhibited by the 
treatment with VPGVG dose-dependently (Fig. 2a). Elastin 
level in the cell layer was slightly reduced (Fig. 2b). Relative 
elastin synthesis in the combination of the medium and cell 
layer measured by autoradiograms demonstrated that maxi- 
mum inhibition of one third of control was achieved at the 
concentration of 10 -6 M during 48 h treatment (Fig. 2, right 
panel). In contrast, VGVAPG exhibited no significant effect on 
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Fig. 1. Effect of TPA and various elastin peptides on cell proliferation. 
Quiescent cultures were treated for 48 h with TPA (a) or various elastin 
peptide (b-f) at the concentrations indicated. At the termination of 
incubation, cells were trypsinized and the numbers of cells were 
counted. Values are mean + deviations obtained from triplicate xperi- 
ments. 
elastin synthesis (Fig. 3a and b). Similar results were obtained 
with the polymers of VPGVG and VGVAPG (Fig. 4a and b). 
Neither VPGVG nor VGVAPG resulted in a significant 
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Fig. 2. Effect of elastin peptide, VPGVG, on elastin synthesis. Cultures were treated for 48 h with elastin fragment VPGVG at the concentrations 
of 0 (lane 1), 10 -8 (lane 2), 10 -7 (lane 3) and 10 ~ M (lane 4), then labeled with [3H]valine for the last 6 h. The proteins in the medium (a) and cell 
layer (b) were processed to SDS-PAGE followed by autoradiography. Arrows indicate the position of elastin. Autoradiograms were scanned with 
a densitometer. Relative lastin synthesis in the medium and cell layer was combined and expressed as a percentage of total protein synthesis (right 
panel). Values are mean _+ deviation from duplicate xperiments. 
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Fig. 3. Effect of elastin peptide, VGVAPG, on elastin synthesis. Cultures were treated for 48 h with elastin peptide VGVAPG at the concentrations 
of 0 (lane 1), 10 -s (lane 2), 10 -7 (lane 3) and 10 6 M (lane 4), then labeled with [3H]valine for the last 6 h. The proteins in the medium (a) and cell 
layer (b) were processed to SDS-PAGE and relative lastin synthesis was determined asdescribed in Fig. 2 (right panel). Arrows indicate the position 
of elastin. 
change in collagen and total protein syntheses as measured by 
bacterial collagenase digestion (Table 1). 
The level of elastin mRNA was also reduced with the treat- 
ments of both form of VPGVG by one half of control at the 
concentration of 10 -6 M for 48 h treatment (Fig. 5a and b, 
upper panels). In contrast VGVAPG did not alter elastin 
mRNA level at the concentrations between 10 -8 and 10 -6 M 
(Fig. 5c and d, upper panels). Both peptides did not change the 
level of GAPDH mRNA (Fig. 5a-d, lower panels). 
4. Discussion 
It has been reported that tropoelastin and elastin digests 
produced by elastase are chemoattractants for monocytes and 
fibroblasts [23] or elastin degradation products (K elastin) acti- 
vate calcium influx in monocytes, fibroblasts and SMCs [24,25]. 
Although there is no direct evidence that elastin fragments used 
in this experiments exist as degradation products in vivo, these 
previous reports uggest that elastin degradation products actu- 
ally exert an effect on cell migration. 
The results obtained here clearly demonstrated that ex- 
ogenously added elastin fragment. VPGVG and its polymer, 
stimulated cell proliferation and, at the same time, inhibited 
elastin expression. The simultaneous modulations for cell pro- 
liferation and elastin expression have been demonstrated; po- 
tent stimulators for SMC proliferation like EGF [26], angioten- 
sin II [27], high K + concentration [17] and TPA (Wachi, H. and 
Tajima, S., in preparation) have been reported to inhibit elastin 
synthesis by SMCs. Therefore the decreased elastin expression 
by elastin fragment may be related to its stimulatory effect on 
cell proliferation. 
The inhibition of elastin expression by elastin fragments may 
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Fig. 4. Effect of elastin peptide polymers on elastin synthesis. Cultures were treated for 48 h with (VPGCG), (a) or (VGVAPG), (b) at the 
concentrations of 0 (lane 1), 0.01 (lane 2), 0.1 (lane 3) and 1.0 pg/ml (lane 4), then labeled with [3H]valine for the last 6 h. The proteins in the medium 
and cell layer were processed to SDS-PAGE and relative lastin synthesis was determined as described in Fig. 2 (right panel). Autoradiograms of 
medium alone were shown in this figure. 
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Fig. 5. Elastin mRNA level of the cells treated with the elastin fragment. Cells were treated with VPGVG (a), (VPGVG), (b), VGVAPG (c) or 
(VGVAPG), (d) for 48 h at the concentrations i dicated. RNA was isolated and resolved on 1% agarose gel electrophoresis, then blotted onto 
nitrocellulose filters. The membrane was hybridized with 32p-labeled elastin (upper panels) and GAPDH (lower panels) cDNAs. The blots were 
autoradiographed and scanned with a densitometer. 
reflect the negative feedback regulatory mechanism by which 
elastin synthesis is controlled under normal and the diseased 
states. The modulation may be important o maintain a fine 
balance between synthesis and degradation of elastin in the 
normal condition and, moreover, to balance the accumulated 
elastin in the elastogenic tissues uch as atherosclerosis. Nega- 
tive autoregulation of elastin gene expression has been indi- 
rectly suggested when elastin secretion was inhibited by monen- 
sin [28] or elastin cross-linking formation was inhibited by the 
addition of BAPN [29]. Our results provided a direct evidence 
that the treatment of SMC with elastin fragment VPGVG re- 
sulted in the autoregulation of elastin expression. Similar au- 
toregulations have been also reported in collagen synthesis in 
which N-propeptide of type I procollagen inhibited collagen 
synthesis and mRNA activities [30-32]. 
The modulations were found in the sequence VPGVG but 
not in VGVAPG. Since chicken tropoelastin has no repeating 
hexa- or nonapeptide [4], VPGVG appears to be an essential 
sequence for autoregulation of elastin synthesis and may be 
specifically recognized by chick SMCs. The modulation may be 
specific to elastin molecule, since collagen and total protein 
syntheses were essentially unchanged. 
Although we have not studied the reactivity of elastin frag- 
ment VPGVG with SMC cellular membrane, the peptide is 
highly likely to interact with cell membrane because VGVAPG, 
a hexapeptide repeated multiple times in bovine, porcine and 
human elastin molecules has been already shown to bind to 
elastin receptors in the cell membrane [12]. VPGVG sequence 
Table 1 
Effect of elastin peptides on collagen synthesis 
Peptides Concentra- Collagen Total protein Relative 
tion (cprn/cell) (cprn/cell) collagen 
(M) synthesis (%) 
None 0.62 + 0.03 1.4 -+ 0.2 44 
VPGVG 10 -7 0.60 + 0.05 1.4 + 0.2 43 
10 -6 0.60 -+ 0.03 1.4 -+ 0.3 43 
VGVAPG 10 -7 0.68 +0.04 1.5 + 0.3 45 
10 -6 0.60 + 0.05 1.4 + 0.4 43 
Cultures were treated for 48 h with polymeric elastin peptides at the 
concentrations of 0.1 or 1.0/~g/ml, then labeled with [3H]proline for the 
last 6 h in the presence of ascorbic acid (50 pg/ml). The proteins in the 
medium and cell layer were combined and collagen synthesis was deter- 
mined by bacterial collagenase digestion. Relative collagen synthesis 
was expressed by collagen synthesis/total protein synthesis. Values are 
mean + deviation from duplicate xperiments. 
is the ubiquitous pentapeptide found in the elastin molecules 
of all animal species analyzed. Unlike other repeating elastin 
fragments, it has a unique elastic property in vitro [33,34], 
suggesting that VPGVG plays an essential role in elastin metab- 
olism in normal and diseased states as well as in maintaining 
the elastic structure. 
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